Waarde Capital

KOKO Networks Ltd is a technology company founded in 2014 and headquartered in Nairobi, Kenya. It operates in emerging markets, particularly in East Africa and India, focusing on smart commerce solutions. KOKO Networks offers a unique platform that connects suppliers, retailers, and customers, facilitating the delivery of various consumer and business services aimed at enhancing urban life in Africa. By leveraging its technology, KOKO Networks aims to improve accessibility and efficiency in commerce, contributing to the development of urban economies in the region.

HyPoint, Inc. is developing the next generation hydrogen fuel cell system with zero CO2 emissions and game-changing energy performance for the air transportation and urban air mobility market. Our solution increases operational time by 5X and utilization rate by 10X while decreasing TCO of any flying platform by 90%.

Gauzy is currently a leading provider of turnkey liquid crystal glass projects, installing laminated LC films in different applications such as home appliances, architecture, construction, automotive industry and many other segmented markets. Their patent pending innovative control technologies enable us to handle glass like never before – Dim glass with numerous stages of transparency, create in-glass blinds, insert transparent solar cells into glass windows, and achieve various glass related innovations in the automotive and aviation industries.

Sabi Am is a category agnostic B2B network for informal trade focused on accelerating the velocity of commerce by enabling stakeholders in the informal sector to access and offer value amongst each other.

Sabi Am is a category agnostic B2B network for informal trade focused on accelerating the velocity of commerce by enabling stakeholders in the informal sector to access and offer value amongst each other.

Bartini Aero specializes in the development of electric vertical take-off and landing aircraft. The company was founded in 2015 and is based in Cupertino, California.

ExonLab is a company dedicated to developing solutions for cloud, blockchain and IoT. ExonLab has co-developed Containerum Platform for managing applications in Kubernetes. ExonLab provides Kubernetes installation and support services for B2B and B2C customers in the Russian market and develops Kubernetes as a Service solutions for data centers.

Xplenty’s cloud-based, easy-to-use, data integration service makes it easy to move, process and transform more data, faster, reducing preparation time so businesses can unlock insights quickly. With an intuitive drag-and-drop interface it’s a zero-coding experience. Xplenty processes both structured and unstructured data and integrates with a variety of sources, including SQL data stores, NoSQL databases and cloud storage services.

Gauzy is currently a leading provider of turnkey liquid crystal glass projects, installing laminated LC films in different applications such as home appliances, architecture, construction, automotive industry and many other segmented markets. Their patent pending innovative control technologies enable us to handle glass like never before – Dim glass with numerous stages of transparency, create in-glass blinds, insert transparent solar cells into glass windows, and achieve various glass related innovations in the automotive and aviation industries.

Utilight Ltd., founded in 2008 and based in Yavne, Israel, specializes in innovative technologies for harnessing solar energy. The company has developed a patented Pattern Transfer Printing (PTP™) technology aimed at enhancing the photovoltaic (PV) metallization process for crystalline silicon solar cells. This technology not only improves solar cell efficiency but also reduces manufacturing costs, making solar energy more affordable. Following a successful feasibility study, Utilight secured investments from venture funds and support from the Israeli office of Chief Scientist to advance its commercial products for the solar PV industry. The company has established strategic partnerships with leading solar cell manufacturers in China and Taiwan, further solidifying its position in the renewable energy sector.

GetGoing is a venture-backed San Francisco startup changing the way people travel by making it more fun and affordable. Our goal is to help leisure travelers discover new getaways, save big (up to 40%) and travel more. We are working with major airlines and hotels to revolutionize the travel industry while delivering the best experience and prices to our users. Currently, we fly to over 2000 destinations worldwide. Our proprietary pricing method helps airlines fill unsold seats (up to 20% of available seats) by selling to discretionary, price-sensitive leisure travelers. To purchase a ticket on our website, customers need to select two destinations and commit to a non-refundable purchase. During the flight selection process, customers can choose arrival and departure times, flight duration, and the number of stops. GetGoing selects one of the destinations, revealing it to the customer after processing the booking and payment. Since our model requires destination flexibility, we ensure that our sales exclude business travelers, those visiting friends and family, and non-flexible leisure customers. We have eight U.S. and international patents and keep expanding our intellectual property portfolio with innovative pricing, search and customer segmentation methods.

Xplenty’s cloud-based, easy-to-use, data integration service makes it easy to move, process and transform more data, faster, reducing preparation time so businesses can unlock insights quickly. With an intuitive drag-and-drop interface it’s a zero-coding experience. Xplenty processes both structured and unstructured data and integrates with a variety of sources, including SQL data stores, NoSQL databases and cloud storage services.

GetGoing is a venture-backed San Francisco startup changing the way people travel by making it more fun and affordable. Our goal is to help leisure travelers discover new getaways, save big (up to 40%) and travel more. We are working with major airlines and hotels to revolutionize the travel industry while delivering the best experience and prices to our users. Currently, we fly to over 2000 destinations worldwide. Our proprietary pricing method helps airlines fill unsold seats (up to 20% of available seats) by selling to discretionary, price-sensitive leisure travelers. To purchase a ticket on our website, customers need to select two destinations and commit to a non-refundable purchase. During the flight selection process, customers can choose arrival and departure times, flight duration, and the number of stops. GetGoing selects one of the destinations, revealing it to the customer after processing the booking and payment. Since our model requires destination flexibility, we ensure that our sales exclude business travelers, those visiting friends and family, and non-flexible leisure customers. We have eight U.S. and international patents and keep expanding our intellectual property portfolio with innovative pricing, search and customer segmentation methods.

Bioxis Pharmaceuticals SAS is a Lyon-based company that specializes in the development, manufacturing, and supply of biomaterials for regenerative medicine. Its product portfolio includes MTI-12, a monophasic tissular inductor designed for aesthetic dermatology, and Cytosial, a monophasic hyaluronic acid aimed at reducing signs of aging. The company markets its products through retail outlets in France. Established in 2010, Bioxis Pharmaceuticals was formerly known as Cytosial Biomedic, S.a.s. and rebranded in July 2016. The company is certified ISO 13485 and employs a team of ten individuals, including senior management with extensive experience in the aesthetic dermatology sector. Bioxis has received support from Medicen, a life sciences cluster in the Paris Region, and BPI France, the French public investment bank.

Bioxis Pharmaceuticals SAS is a Lyon-based company that specializes in the development, manufacturing, and supply of biomaterials for regenerative medicine. Its product portfolio includes MTI-12, a monophasic tissular inductor designed for aesthetic dermatology, and Cytosial, a monophasic hyaluronic acid aimed at reducing signs of aging. The company markets its products through retail outlets in France. Established in 2010, Bioxis Pharmaceuticals was formerly known as Cytosial Biomedic, S.a.s. and rebranded in July 2016. The company is certified ISO 13485 and employs a team of ten individuals, including senior management with extensive experience in the aesthetic dermatology sector. Bioxis has received support from Medicen, a life sciences cluster in the Paris Region, and BPI France, the French public investment bank.

GetGoing is a venture-backed San Francisco startup changing the way people travel by making it more fun and affordable. Our goal is to help leisure travelers discover new getaways, save big (up to 40%) and travel more. We are working with major airlines and hotels to revolutionize the travel industry while delivering the best experience and prices to our users. Currently, we fly to over 2000 destinations worldwide. Our proprietary pricing method helps airlines fill unsold seats (up to 20% of available seats) by selling to discretionary, price-sensitive leisure travelers. To purchase a ticket on our website, customers need to select two destinations and commit to a non-refundable purchase. During the flight selection process, customers can choose arrival and departure times, flight duration, and the number of stops. GetGoing selects one of the destinations, revealing it to the customer after processing the booking and payment. Since our model requires destination flexibility, we ensure that our sales exclude business travelers, those visiting friends and family, and non-flexible leisure customers. We have eight U.S. and international patents and keep expanding our intellectual property portfolio with innovative pricing, search and customer segmentation methods.